期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 17, 页码 6457-6465出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm1007853
关键词
-
资金
- Canadian Institute of Health Research (CIHR) [MOP-97878]
- Natural Sciences and Engineering Research Council (NSERC) [138216-09]
- British Columbia Cancer Studentship
Anthracyclines are powerful chemotherapeutic agents for the treatment of many cancers. In many instances, they are currently used in combination with histone deacetylase inhibitors in order to enhance their efficiency. Not surprisingly and as part of their mode of action, these drugs interfere with gene expression, a process that has long been known to be mediated by histone acetylation. In this paper, we use analytical ultracentrifuge analysis, equilibrium dialysis, and circular dichroism to characterize the role of histone acetylation on the binding of antharcyclines to chromatin. We show that histone acetylation enhances the daunomycin-induced DNA dissociation from nucleosomes and decreases the extent of aggregation that results from the interaction in a way that is modulated by the presence or absence of linker histones. Histone acetylation increases the binding affinity of daunomycin by chromatin. Furthermore, the binding of anthracycline to acetylated chromatin sheds additional light into the conformational chromatin alterations resulting from core histone acetylation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据